Skip to main content
Tech.euFundingExplorerBeta

QurieGen

AI-based technology aimed at accelerating drug development progress in oncology

QurieGen has raised €2.2M across 1 funding round from 5 investors, most recently a Pre-Seed round in Apr 2025. Based in Nijmegen, Netherlands; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€2.2M
€2,200,000
Funding rounds
1
Investors
5
distinct backers
Active since
2025-04
latest 2025-04

Funding by year

EUR raised per year
QurieGen — funding by year — interactive chart.
Data table
QurieGen — funding by year
2025€2.2M

Signals

High confidence
Raise-next likelihood28
base rate 24% for Pre-Seed
  • ▲ In typical raise window
  • ▼ Low backer re-investment

Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round

Related news

Similar companies

same sector or country

Global coverage: FundingData